project id: TCGA-HNSC; case submitter id: TCGA-BB-8596; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.23; rna integrity number: 7.3; age at index: 69; days to birth: -25408; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1936; age at diagnosis: 25408; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage IVA; ajcc clinical t: T4; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2161.0; icd 10 code: C13.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Hypopharynx, NOS; synchronous malignancy: No; tissue or organ of origin: Hypopharynx, NOS; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Yes; cigarettes per day: 2.73972602739726; pack years smoked: 50.0; years smoked: 50.0; is ffpe: false; weight: 40.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.4; longest dimension: 0.6; oct embedded: No; shortest dimension: 0.2; portion submitter id: TCGA-BB-8596-01A-11; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 65.0;